Synopsis of recent research by authors named "Reem Altaf"
- Reem Altaf's recent research primarily focuses on the development and validation of therapeutic strategies for diseases like non-small cell lung cancer (NSCLC) and type 2 diabetes, utilizing bioinformatics and pharmacological approaches.
- Key findings include the identification of differentially expressed genes for potential NSCLC biomarkers, and the formulation of novel morpholine-acetamide derivatives as promising anti-tumor drug candidates through molecular docking studies.
- Additional studies explore the repositioning of FDA-approved drugs for cancer therapy, anti-diabetic effects of newly synthesized compounds, and advancements in immune checkpoint inhibitors, highlighting the multifaceted nature of her contributions to cancer and metabolic disease research.